4.91 USD
↘ 0.15 (2.96%)AT CLOSE (03:59 PM EST)
Shares of Bolt Biotherapeutics, Inc. Common Stock (BOLT) are trading at $4.91. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Nov 20, 2026.